SE0100567D0 - Compounds - Google Patents

Compounds

Info

Publication number
SE0100567D0
SE0100567D0 SE0100567A SE0100567A SE0100567D0 SE 0100567 D0 SE0100567 D0 SE 0100567D0 SE 0100567 A SE0100567 A SE 0100567A SE 0100567 A SE0100567 A SE 0100567A SE 0100567 D0 SE0100567 D0 SE 0100567D0
Authority
SE
Sweden
Prior art keywords
compounds
compound
relates
present
gnrh
Prior art date
Application number
SE0100567A
Other languages
English (en)
Swedish (sv)
Inventor
Alexander Dossetter
Peter Kenny
Darren Mckerrecher
Michael Wardleworth
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0100567A priority Critical patent/SE0100567D0/xx
Publication of SE0100567D0 publication Critical patent/SE0100567D0/xx
Priority to AU2002229976A priority patent/AU2002229976A1/en
Priority to PCT/GB2002/000634 priority patent/WO2002066477A2/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE0100567A 2001-02-20 2001-02-20 Compounds SE0100567D0 (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE0100567A SE0100567D0 (sv) 2001-02-20 2001-02-20 Compounds
AU2002229976A AU2002229976A1 (en) 2001-02-20 2002-02-15 Imidazopyridines
PCT/GB2002/000634 WO2002066477A2 (fr) 2001-02-20 2002-02-15 Composes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0100567A SE0100567D0 (sv) 2001-02-20 2001-02-20 Compounds

Publications (1)

Publication Number Publication Date
SE0100567D0 true SE0100567D0 (sv) 2001-02-20

Family

ID=20283057

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0100567A SE0100567D0 (sv) 2001-02-20 2001-02-20 Compounds

Country Status (3)

Country Link
AU (1) AU2002229976A1 (fr)
SE (1) SE0100567D0 (fr)
WO (1) WO2002066477A2 (fr)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10246890A1 (de) * 2002-10-08 2004-04-22 Grünenthal GmbH Substituierte C-Imidazo[1,2-alpyridin-3-yl-methylamine
DE10247271A1 (de) * 2002-10-10 2004-08-26 Grünenthal GmbH Substituierte C-Imidazo[1,2-a]pyridin-3-yle
GB0320806D0 (en) 2003-09-05 2003-10-08 Astrazeneca Ab Therapeutic treatment
CA2544213A1 (fr) 2003-10-28 2005-05-19 Sepracor Inc. Anxiolytiques d'imidazo[1,2-a]pyridine
GB0403781D0 (en) * 2004-02-20 2004-03-24 Astrazeneca Ab Chemical compounds
JP2008506702A (ja) 2004-07-14 2008-03-06 ピーティーシー セラピューティクス，インコーポレーテッド Ｃ型肝炎を治療するための方法
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7868037B2 (en) 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7772271B2 (en) 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
WO2006019832A1 (fr) 2004-07-22 2006-02-23 Ptc Therapeutics, Inc. Thienopyridines utilisees pour traiter l'hepatite c
EP1961745A1 (fr) 2005-12-12 2008-08-27 Ono Pharmaceutical Co., Ltd. Compose heterocyclique bicyclique
CN101410397A (zh) * 2006-03-31 2009-04-15 诺瓦提斯公司 有机化合物
WO2008027812A2 (fr) 2006-08-28 2008-03-06 Forest Laboratories Holdings Limited Dérivés d'imidazopyridine et d'imidazopyrimidine
JP5159630B2 (ja) 2006-09-13 2013-03-06 協和発酵キリン株式会社 縮環複素環誘導体
WO2008078091A1 (fr) 2006-12-22 2008-07-03 Astex Therapeutics Limited Composés hétérocycliques bicycliques servant d'inhibiteurs des fgfr
WO2008078100A2 (fr) 2006-12-22 2008-07-03 Astex Therapeutics Limited Nouveaux composés
EP1964840A1 (fr) 2007-02-28 2008-09-03 sanofi-aventis Imidazo[1,2-a]pyridines et leur utilisation en tant que produits pharmaceutiques
CN103214482B (zh) 2007-04-03 2016-06-29 阵列生物制药公司 作为受体酪氨酸激酶抑制剂的咪唑并[1,2-a]吡啶化合物
GB0720038D0 (en) 2007-10-12 2007-11-21 Astex Therapeutics Ltd New compounds
GB0720041D0 (en) 2007-10-12 2007-11-21 Astex Therapeutics Ltd New Compounds
CA2703649A1 (fr) * 2007-10-24 2009-04-30 Shigeyuki Tanifuji Nouveau compose possedant une affinite vis-a-vis d'une substance amyloide
US8497278B2 (en) * 2008-05-19 2013-07-30 Sunovion Pharmaceuticals Inc. Imidazo[1,2-a]pyridine compounds
GB0810902D0 (en) 2008-06-13 2008-07-23 Astex Therapeutics Ltd New compounds
GB0906472D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
GB0906470D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
TW201242965A (en) 2011-02-01 2012-11-01 Kyowa Hakko Kirin Co Ltd Ring-fused heterocyclic derivative
US8975276B2 (en) 2011-06-29 2015-03-10 Bristol-Myers Squibb Company Inhibitors of PDE10
US8883819B2 (en) 2011-09-01 2014-11-11 Irm Llc Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
CN104619707A (zh) 2012-07-31 2015-05-13 协和发酵麒麟株式会社 稠环杂环化合物
US9073921B2 (en) 2013-03-01 2015-07-07 Novartis Ag Salt forms of bicyclic heterocyclic derivatives
MA52119A (fr) 2015-10-19 2018-08-29 Ncyte Corp Composés hétérocycliques utilisés comme immunomodulateurs
SG10202004618TA (en) 2015-11-19 2020-06-29 Incyte Corp Heterocyclic compounds as immunomodulators
MD3394033T2 (ro) 2015-12-22 2021-04-30 Incyte Corp Compuși heterociclici ca imunomodulatori
US9926316B2 (en) * 2016-03-03 2018-03-27 The Cleveland Clinic Foundation Antitumor derivatives for differentiation therapy
US20170320875A1 (en) 2016-05-06 2017-11-09 Incyte Corporation Heterocyclic compounds as immunomodulators
WO2017205464A1 (fr) 2016-05-26 2017-11-30 Incyte Corporation Composés hétérocycliques utilisés comme immunomodulateurs
LT3472167T (lt) 2016-06-20 2022-11-10 Incyte Corporation Heterocikliniai junginiai kaip imunomoduliatoriai
US20180016260A1 (en) 2016-07-14 2018-01-18 Incyte Corporation Heterocyclic compounds as immunomodulators
US20180057486A1 (en) 2016-08-29 2018-03-01 Incyte Corporation Heterocyclic compounds as immunomodulators
KR102641030B1 (ko) 2016-12-22 2024-02-29 인사이트 코포레이션 Pd-l1 내재화 유도제로서의 테트라하이드로 이미다조[4,5-c]피리딘 유도체
WO2018119236A1 (fr) 2016-12-22 2018-06-28 Incyte Corporation Dérivés de triazolo[1,5-a]pyridine en tant qu'immunomodulateurs
MA47120A (fr) 2016-12-22 2021-04-28 Incyte Corp Dérivés pyridine utilisés en tant qu'immunomodulateurs
BR112019012993A2 (pt) 2016-12-22 2019-12-03 Incyte Corp derivados de benzo-oxazol como imunomoduladores
LT3774791T (lt) 2018-03-30 2023-04-11 Incyte Corporation Hererocikliniai junginiai kaip imunomoduliatoriai
HRP20230306T1 (hr) 2018-05-11 2023-05-12 Incyte Corporation Derivati tetrahidro-imidazo[4,5-c]piridina kao pd-l1 imunomodulatori
WO2021030162A1 (fr) 2019-08-09 2021-02-18 Incyte Corporation Sels d'un inhibiteur de pd-1/pd-l1
KR20220075382A (ko) 2019-09-30 2022-06-08 인사이트 코포레이션 면역조절제로서의 피리도[3,2-d]피리미딘 화합물
MX2022005651A (es) 2019-11-11 2022-07-27 Incyte Corp Sales y formas cristalinas de un inhibidor de la proteina de muerte celular programada 1 (pd-1)/ligando de muerte celular programada 1 (pd-l1).
WO2022099018A1 (fr) 2020-11-06 2022-05-12 Incyte Corporation Procédé de préparation d'un inhibiteur de pd-1/pd-l1
AU2021373044A1 (en) 2020-11-06 2023-06-08 Incyte Corporation Process for making a pd-1/pd-l1 inhibitor and salts and crystalline forms thereof
WO2022099075A1 (fr) 2020-11-06 2022-05-12 Incyte Corporation Forme cristalline d'un inhibiteur pd-1/pd-l1
CN113666926A (zh) * 2021-09-08 2021-11-19 桂林理工大学 一种便捷的2-苯基咪唑[1,2-a]吡啶与查尔酮的Michal加成反应

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19544212A1 (de) * 1995-11-28 1997-06-05 Asta Medica Ag Neue LH-RH-Antagonisten mit verbesserter Wirkung
EP0912562A1 (fr) * 1996-07-19 1999-05-06 Takeda Chemical Industries, Ltd. Composes heterocycliques, leur production et leur utilisation
EP1028690A2 (fr) * 1997-10-20 2000-08-23 Novo Nordisk A/S Antagonistes de l'hormone luteinisante utiles pour le traitement de carences oestrogeniques ou utilises en tant que contraceptif
AU2597299A (en) * 1998-02-11 1999-08-30 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
EP1062215A4 (fr) * 1998-02-11 2001-03-14 Merck & Co Inc Antagonistes de l'hormone de liberation de la gonadotrophine
MXPA02006848A (es) * 2000-01-25 2002-12-13 Neurocrine Bioscience Inc Antagonistas del receptor de la hormona liberadora de gonadotropina.
ES2244613T3 (es) * 2000-04-27 2005-12-16 Astellas Pharma Inc. Derivados de imidazopiridina.

Also Published As

Publication number Publication date
AU2002229976A1 (en) 2002-09-04
WO2002066477A2 (fr) 2002-08-29
WO2002066477A3 (fr) 2002-10-17

Similar Documents

Publication Publication Date Title
SE0100567D0 (sv) Compounds
SE0100568D0 (sv) Compounds
SE0200979D0 (sv) New compounds
TW200745111A (en) New compounds
DE69533174D1 (de) Pyridopyrimidinone, chinoline und anellierte n-heterozyklen als bradykinin-antagonisten
SE0100569D0 (sv) New compounds
UY27368A1 (es) Nuevos compuestos
DK1317419T3 (da) Cyanophenoxycarboxylsyre-forbindelser og sammensætninger til at levere aktive midler
MXPA04005209A (es) Antagonistas del receptor de adenosina a2a.
DE60234577D1 (de) Pharmazeutische mischung zur behandlung von krebs, die dioxolan nukleosidanalogen enthält
MXPA04005156A (es) Antagonistas del receptor de adenosina a2a.
SE0100566D0 (sv) Compounds
GB0112348D0 (en) Compounds
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
TW200606164A (en) New compounds
BR0315777A (pt) Uso de derivados de piperazina como antagonistas ccr1
UY27593A1 (es) Nuevos compuestos
SE0102440D0 (sv) New compound
DK1458393T3 (da) Substituerede diketopiperaziner som oxytocinantagonister
AR037521A1 (es) Derivados de piperazina que tienen actividad antagonista del sst1, un proceso para su preparacion, composicion farmaceutica y el uso de dichos derivados para la manufactura de un medicamento para el tratamiento de la depresion, ansiedad y padecimientos bipolares y una combinacion
SE0101692D0 (sv) Compounds
HK1075894A1 (en) Prucalopride-n-oxide
ATE384066T1 (de) Thieno-pyrrole verbindungen als antagonisten der gonadotropin-freisetzenden hormonrezeptoren
NO20064298L (no) Piperazinureaderivater til behandling av endometriose
DE60114597D1 (de) Naphthamid-neurokinin antagonisten zur verwendung als medikamente